Form 13-F position report

ORAMED PHARM INC

Reported by SG Americas Securities LLC

ORMP CUSIP 68403P203 Manager CIK 0001313360

Reported 0 shares, down 10,370 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2023
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 7 Through Q1 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 298000
2021-12-31 123000
2022-03-31 0
2022-06-30 213000
2022-09-30 67000
2022-12-31 125000
2023-03-31 0
2025-03-31 50000
2025-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

9 quarters
Quarterly reported position history for ORAMED PHARM INC held by SG Americas Securities LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2025 Reduced 0 -23,446 (-100.0%) 0 $0 2025-08-08
Q1 2025 New 23,446 +23,446 (0.0%) < 0.01% $50,000 2025-04-15
Q1 2023 Reduced 0 -10,370 (-100.0%) 0 $0 2023-04-28
Q4 2022 Unchanged 10,370 0 (0.0%) < 0.01% $125,000 2023-02-02
Q3 2022 Reduced 10,370 -36,162 (-77.7%) < 0.01% $67,000 2022-10-31
Q2 2022 New 46,532 +46,532 (0.0%) < 0.01% $213,000 2022-07-29
Q1 2022 Reduced 0 -8,631 (-100.0%) 0 $0 2022-04-29
Q4 2021 Reduced 8,631 -4,910 (-36.3%) < 0.01% $123,000 2022-02-07
Q3 2021 New 13,541 +13,541 (0.0%) < 0.01% $298,000 2021-11-01

Who else reported the position

90 managers reported ORAMED PHARM INC for Q1 2023.

Managers reporting ORAMED PHARM INC in Q1 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BML Capital Management LLC New 1,355,925 +1,355,925 2.56% $2,955,917 1 qtr
TWO SIGMA INVESTMENTS LP New 506,255 +506,255 < 0.01% $1,103,636 6 qtrs
TWO SIGMA ADVISERS LP Added 444,900 +193,000 < 0.01% $969,882 6 qtrs
MORGAN STANLEY Reduced 284,136 -32,255 < 0.01% $619,417 38 qtrs
JPMorgan Chase & Co Reduced 174,122 -230,495 < 0.01% $379,000 8 qtrs
MILLENNIUM MANAGEMENT LLC Reduced 165,770 -324,433 < 0.01% $361,000 15 qtrs
XTX Topco Ltd Added 151,620 +94,537 0.07% $330,532 6 qtrs
Susquehanna International Group Ltd New 113,526 +113,526 0.14% $247,487 1 qtr
The Goldman Sachs Group Inc Added 100,954 +84,447 < 0.01% $220,080 9 qtrs
UBS Group AG Added 99,134 +88,422 < 0.01% $216,112 34 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2023
Filed
April 28, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.